Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caron A Jacobson

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Hematology/Oncology Clinics of North America|June 24, 2019
Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin LymphomaBradley D Hunter, Yi-Bin Chen, Caron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Unusual uterine recurrence of primary central nervous system lymphomaGwen L Nichols, Caron A Jacobson, Debra Ferman, et al.
Nature Medicine|November 8, 2022
Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphomaEdward R Scheffer Cliff, Reid W Merryman, Philippe Armand, et al.
JAAD Case Reports|February 12, 2026
Durable remission of primary testicular diffuse large B-cell lymphoma with secondary cutaneous involvement with chimeric antigen receptor T-cell therapyNicole Trepanowski, Robert E LeBlanc, Caron A Jacobson, et al.
American Journal of Hematology|June 11, 2024
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapyHazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Neurology. Clinical Practice|January 7, 2022
Myelopathy Because of CAR-T-Related Neurotoxicity Treated With SiltuximabYasmin Aghajan, Alison Yu, Caron A Jacobson, et al.
Blood Advances|July 3, 2023
A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndromeCaron A Jacobson, Allison C Rosenthal, Jon Arnason, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cell-free RNA Signatures Derived from the Tumor Microenvironment Predict Outcomes of CAR-T Therapy in Large B Cell LymphomaConor Loy, Glory Agun, Katie Maurer, et al.
Open Forum Infectious Diseases|September 3, 2024
Disseminated <i>Mycobacterium avium</i> Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular LymphomaJessica S Little, Rocio M Hurtado, Nicholas Boire, et al.
Haematologica|June 15, 2023
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapyHazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Hematology/Oncology Clinics of North America|June 24, 2019
Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin LymphomaBradley D Hunter, Yi-Bin Chen, Caron A Jacobson
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Unusual uterine recurrence of primary central nervous system lymphomaGwen L Nichols, Caron A Jacobson, Debra Ferman, et al.
Nature Medicine|November 8, 2022
Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphomaEdward R Scheffer Cliff, Reid W Merryman, Philippe Armand, et al.
JAAD Case Reports|February 12, 2026
Durable remission of primary testicular diffuse large B-cell lymphoma with secondary cutaneous involvement with chimeric antigen receptor T-cell therapyNicole Trepanowski, Robert E LeBlanc, Caron A Jacobson, et al.
American Journal of Hematology|June 11, 2024
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapyHazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Neurology. Clinical Practice|January 7, 2022
Myelopathy Because of CAR-T-Related Neurotoxicity Treated With SiltuximabYasmin Aghajan, Alison Yu, Caron A Jacobson, et al.
Blood Advances|July 3, 2023
A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndromeCaron A Jacobson, Allison C Rosenthal, Jon Arnason, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cell-free RNA Signatures Derived from the Tumor Microenvironment Predict Outcomes of CAR-T Therapy in Large B Cell LymphomaConor Loy, Glory Agun, Katie Maurer, et al.
Open Forum Infectious Diseases|September 3, 2024
Disseminated <i>Mycobacterium avium</i> Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular LymphomaJessica S Little, Rocio M Hurtado, Nicholas Boire, et al.
Haematologica|June 15, 2023
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapyHazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Pageof 14